Previously, it has been implied that altered activity of NRG/ErbB signaling plays a role in AD pathogenesis [41] since ErbB4 has been reported to undergo presinilin-dependent gamma-secretase cleavage [42,43]. Here, ERBB4 is linked to Alzheimer disease.